BackKaryopharm Therapeutics Overview

Karyopharm Therapeutics Other Income Expense Net

Other Income/Expense Net for KPTI.

Quarterly Other Income/Expense

$4.37M
↓ 55.55% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$110.75M
↓ 296.23% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin